N.C. reimbursement law to benefit Impedimed

Device firm Impedimed is expected to benefit from the North Carolina regulation that starting Jan. 1 would require health insurers to pay physicians who screen breast cancer patients for lymphoedema. Impedimed manufactures L-Dex system, which is the only device cleared by the FDA for use in early detection of the condition.

View Full Article in:

Herald Sun (Melbourne, Australia) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY